Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Myriad Genetics, Inc. < Previous 1 2 3 Next > Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device March 20, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the February 27, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3 February 27, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 February 21, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health February 15, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics February 01, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology January 30, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics January 18, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO January 09, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance December 21, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care December 20, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents November 20, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers November 16, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Participate in Stephens Annual Investment Conference November 09, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Announces Pricing of Upsized Offering of Common Stock November 08, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock November 08, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance November 06, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Appoints Sam Raha as Chief Operating Officer November 01, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023 October 31, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer October 26, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN QGEN New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood September 28, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials September 19, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers ILMN MYGN Myriad Genetics Issues 2022 Environmental, Social and Governance Report September 19, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics and Leading Cancer Center Collaborate to Study the Use of Minimal Residual Disease Testing in Breast Cancer September 18, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work September 06, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women September 06, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference September 05, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk August 22, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN Myriad Genetics to Host Investor Day on September 19, 2023 August 17, 2023 From Myriad Genetics, Inc. Via GlobeNewswire Tickers MYGN < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.